CLINICAL ROLE -
Patient Satisfaction – The True Differentiator for Specialty Pharmacies
A growing number of specialty pharmacy contractual agreements with payers and manufacturers have patient satisfaction metrics built in.
Read More
Study: Patients Forgo EpiPen Treatment Due to High Cost
Annual out-of-pocket spending on EpiPen increased 124% since 2007, according to a recent study.
Thirteen Indicted in Pill Mill and Health Care Fraud Scheme
The indictments contain a combined 477 charges that include counts of money laundering, health care fraud, and unlawfully selling prescriptions of controlled substances.
Clinical Therapy Management Boosts Patient Outcomes
Optimized program can boost adherence and improve reporting capabilities to manufacturers.
Infamous Inmate Mumia Abu-Jamal To Receive Treatment for Hepatitis C
After a prolonged court battle, Abu-Jamal will begin treatment for HCV in prison.
CMS Finalizes 2018 Medicare Advantage, Part D Programs
New policy updates support flexibility and efficiency in Medicare Advantage and Part D plans.
Experimental Compound Reduces Glucose Production in Type 2 Diabetes
Compound may help patients with type 2 diabetes better control glucose levels.
Injectable Implant May be the Future of HIV Prevention
Novel drug delivery system steadily releases preventive HIV drugs over an extended period of time.
Artificial Intelligence May be the Future of Cancer Detection
An artificial intelligence platform detected 92.4% of breast cancer tumors.
FDA Okays Fingernail Psoriasis Data for Humira Prescribing Information
Adalimumab (Humira) demonstrated skin clearance among patients with fingernail psoriasis.
Youth with Diabetes Not Receiving Screenings for Retinopathy
Children with diabetes unlikely to receive ophthalmologic exams in accordance with guidelines.
Trending News Today: Indictments Handed Down in Opioid Distribution Scheme
Top news of the day from across the healthcare landscape.
Alectinib Improves Survival in ALK-Positive Non-Small Cell Lung Cancer
Second phase 3 study meets primary endpoint in improving lung cancer survival.
Lung Cancer Drug Improves Progression-Free Survival in Trial
Alecensa shows promise treating anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer.
Trending News Today: HPV Represents Growing Health Problem in United States
Top news of the day from across the health care landscape.
How to Improve Adherence in Diabetes
Medication adherence among patients with diabetes is often poor.
Benefits to Volunteering on Your Corporate Compliance Team
Many health care entities including hospitals, pharmaceutical manufactures, and retail have in place corporate compliance programs designed to identify fraud, waste, and abuse.
4 Reasons Why Pharmacists Should Visit Disney
Disney World is often thought of as “The Happiest Place on Earth.”
How Pharmacists Can Use Their Knowledge to Create a Dream Career
Meaning for work is essential to our happiness. How to creat that now.
The Cost of Low Health Literacy
We all have a general idea of what low health literacy is, but do we really know how much it costs?
CDC, FDA Investigating After Dead Bat Found in Packaged Salad Product
An investigation is ongoing after packaged salads purchased from a grocery store in Florida were found to contain a dead bat.
Biosimilar Trends Highlight AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
AACR Annual Meeting Highlights Week in Cancer News
Top news of the week in oncology and cancer drug development.
Five Rights Framework Seeks to Improve Dysfunction in Specialty Drug Marketplace
Newly developed framework offers a common ground for specialty pharmacy stakeholders.
Investigational Compound Observed to Render Superbugs Harmless
Antivirulence compounds can prevent superbugs from producing toxins and forming infections.
Combination Hepatitis C Therapy Wins FDA Approval for Pediatric Patients
Sovaldi plus Harvoni approved to treat HCV in children ages 12 to 17.
FDA Approves Hepatitis C Combo Treatment for Pediatric Patients
Sovaldi plus Harvoni is the first direct-acting antiviral treatment approved for children and adolescents aged 12 to 17.
US District Court Invalidates 4 Patents for Multiple Sclerosis Drug Ampyra
Dalfampridine is the only FDA-approved drug to aid walking in patients with MS.
Prime Therapeutics to Manage Specialty Drug Benefits for Government Employees
Pharmacy benefit manager takes CVS Health’s role in providing specialty drug management for Federal Employee Program.
Federal Employee Program Switches Managers of Specialty Drug Program
Pharmacy benefit manager Prime Therapeutics takes over providing specialty pharmacy services from CVS Health for the Blue Cross Blue Shield Federal Employee Program.
